BCL2 and diffuse large B-cell lymphoma: Li et al. evaluated the clinico‐pathological features of DLBCL patients with concurrent atypical MYC and BCL2 rearrangements and compared with DLBCL patients with typical DHITs and found that overall survival between these two groups was similar [39].